稳定性,生物可用性和细胞抗氧化活性与循环葡萄糖复合的皮佩林
Solji Cho1,2, Yunkyoung Jung3, Shin-Joung Rho3
1Department of Biosystems Engineering, Seoul National University, Seoul, 08826 Republic of Korea.
Food science and biotechnology
|June 10, 2025
概括
复杂化piperine与循环葡萄糖,特别是循环胺基 (CA),增强其溶解性,稳定性和生物可用性. 这种包含综合体 (IC) 策略改善了管道.
科学领域:
- 药理学和药物输送 药理学和药物输送
- 自然产品化学 自然产品化学
- 材料科学 材料科学 材料科学
背景情况:
- 黑胡中的活性化合物皮佩林具有较低的溶解性和生物可用性.
- 改善皮佩林的物理化学特性对于其工业应用至关重要.
研究的目的:
- 为了研究 piperine 与周期性葡萄糖 (cycloamylose,α-cyclodextrin,2-hydroxypropyl-β-cyclodextrin) 的复合.
- 评估复杂化对皮佩林可溶性,稳定性,生物可用性和细胞抗氧化活性 (CAA) 的影响.
主要方法:
- 在 piperine 和各种循环葡萄糖之间形成包含综合体 (IC).
- 阶段可溶性研究,以评估可溶性增强.
- 在紫外线,热量和酸性条件下进行稳定性测试.
- 在体外消化和Caco-2细胞单层透性测试.
- 细胞抗氧化剂活性测定.
主要成果:
- 纳入复杂化显著改善了piperine的相位溶解性和稳定性.
- 在体外消化后,ICs增强了piperine的保留,并降低了其排泄率.
- 循环氨基含复合物 (CAIC) 显示了细胞吸收和CAA.最显著的改善.
结论:
- 循环葡萄糖复合,特别是循环胺,是一种有效的策略,可以提高皮佩林的溶解性和生物可用性.
- 这种方法提供了一个实际的解决方案,用于将piperine纳入各种工业应用中.
- 通过循环胺含复合物观察到增强的细胞吸收和抗氧化活性.
相关概念视频
Factors Affecting Dissolution: Drug Permeability, Stability and Stereochemistry
179
Orally administered drugs primarily enter the systemic circulation via passive diffusion through the intestinal membranes. The drug's absorption is influenced by drug stability in the gastrointestinal GI tract, membrane permeability, the surface area available for absorption, luminal drug concentration, and residence time in the lumen. Drug permeability can be enhanced by adjusting the lipophilicity, polarity, or molecular size of the drug, promoting its passive transport across intestinal...
179
Factors Influencing Bioavailability: First-Pass Elimination
6.2K
When a drug is taken orally, it undergoes a journey starting from the gastrointestinal (GI) tract, passing through the portal vein, reaching the liver, and finally entering the systemic circulation. This process involves the absorption of the drug across the GI tract. The liver is the primary site for metabolizing the drug, with some metabolism also occurring in the gut wall. This journey significantly reduces the quantity of the drug that reaches the systemic circulation, a phenomenon known as...
6.2K
Factors Influencing Drug Absorption: Physicochemical Parameters
238
The physicochemical characteristics of drugs play a crucial role in formulating stable and bioavailable drug products. The solubility of a drug, governed by the varying pH along the GI tract and its dissociation constant (pKa), is pivotal in determining its ionization state and absorption rate. Notably, weak acids and bases remain unionized and are absorbed more rapidly.
Enhanced drug absorption can be achieved by reducing particle sizes and increasing surface areas, thereby facilitating...
Enhanced drug absorption can be achieved by reducing particle sizes and increasing surface areas, thereby facilitating...
238
Factors Affecting Dissolution: Drug pKa, Lipophilicity and GI pH
1.2K
Drug absorption within the gastrointestinal (GI) tract is a complex process influenced by several critical factors, including the site pH, the drug's dissociation constant (pKa), and the drug's lipophilicity. The GI tract exhibits a pH gradient, with an acidic environment in the stomach and a more alkaline environment in the small intestine. This pH variation directly affects the ionization state of drugs.
A drug's pKa and the pH of the gastrointestinal (GI) tract play crucial roles...
A drug's pKa and the pH of the gastrointestinal (GI) tract play crucial roles...
1.2K
Factors Influencing Drug Absorption: Pharmaceutical Parameters
122
Solid dosage forms such as tablets and capsules undergo rigorous manufacturing processes to ensure stability and effectiveness. Their dissolution and absorption properties are influenced significantly by the choice of excipients (inactive ingredients that serve various roles in the formulation), and the methodology applied during production. The manufacturing parameters, such as compression force and granulation techniques, significantly affect dissolution rates. Elevated compression forces...
122
Factors Affecting Dissolution: Polymorphism, Amorphism and Pseudopolymorphism
289
Polymorphism refers to the existence of a drug substance in multiple crystalline forms, known as polymorphs. Recently, this term has been expanded to include solvates (forms containing a solvent), amorphous forms (non-crystalline forms), and desolvated solvates (forms from which the solvent has been removed).
Some polymorphic crystals possess lower aqueous solubility than their amorphous counterparts, leading to incomplete absorption. For instance, the oral suspension of Chloramphenicol, which...
Some polymorphic crystals possess lower aqueous solubility than their amorphous counterparts, leading to incomplete absorption. For instance, the oral suspension of Chloramphenicol, which...
289


